π Just published
The READUS-PV guidelines on the Reporting of a Disproportionality Analysis for Drug Safety Signal Detection
https://t.co/5mu90EuGDb
https://t.co/G657WfkpMO
#OpenAcess#Pharmacovigilance
We welcome contributions from Original Research to Review Articles, Clinical Trials, Study Protocols and Case Series related to safety aspects of medication use in the perinatal periods!
With Michael Ceulemans and @SarahObican, we recently launched a new Research Topic entitled "Drug Safety in the Perinatal Period" at Frontiers in Drug Safety and Regulation. Please consider this topic for your future submissions https://t.co/oqVXjEr8qn
Vaccination reduced the risk of #LongCovid by ~40% in the entire population (5.4 million) of Norway
https://t.co/pwVRT1fhh8 and reduced cardiovascular and thrombotic events @NhungPharma@LancetRespirMed
This replication cannot be done without the OMOP Common Data Model and the OHDSI federated analytic pipeline! Many thanks to all the colleagues that were involved! And yes, let's do this more @prieto_alhambra
We have exciting projects on drug repurposing in the era of large-scale observational and genetic data for MSCA postdoc candidates within the DS Train program at University of Oslo! Take a look
https://t.co/LtVaOowRfW and apply here https://t.co/yJmHqwPAH8
@MK_statistics Thank you @MK_statistics! It was a great pleasure to have you with us. We all enjoyed your lecture. Looking forward to your keynote talk today!